16+
Major trials tracked
Immuno-oncology checkpoint inhibitors · Live ClinicalTrials.gov data
Durvalumab (Imfinzi) clinical trial pipeline
The timeline below tracks the 16 largest phase 2–4 durvalumab (Imfinzi) trials on ClinicalTrials.gov by enrolment, 2 of them actively recruiting. The next phase 3 primary completion among them is expected Oct 2031. Refreshed daily. Add up to four competitors to compare pipelines side by side.
6
Phase 3 trials
2
Actively recruiting
Oct 2031
Next phase 3 primary completion
6,449
Participants across trials
AstraZeneca
Lead sponsor by trial count
durvalumab (16)9 active2015–2033
durvalumab
'15
'17
'19
'21
'23
'25
'27
'29
'31
'33
durvalumab
Phase II Study of MEDI4736, Tremelimumab, and MEDI4736 in Combination w/ Tremelimumab Squamous Cell Carcinoma of the Head and NeckP2
KESTRELP3
Multi-Arm Study to Test the Efficacy of Immunotherapeutic Agents in Multiple Sarcoma SubtypesP2
Durvalumab and Tremelimumab in Patients With Advanced Rare TumoursP2
HIMALAYAP3
IMMUCHECP2
CALLAP3
ORCHARDP2
ATOMICCP2
This Study is a Phase II Study of AZD6738 in Combination With Durvalumab in Patients With Solid Tumor (Cohort A (N=30): GC Who Have Failed Secondary Chemotherapy Treatments Regimen; Cohort B (B=30): Melanoma Patients Who Have Failed to IO)P2
Trial of Neoadjuvant Durvalumab Plus Docetaxel, Oxaliplatin, S-1 Followed by Surgery and Adjuvant Durvalumab Plus S-1 Chemotherapy in Potentially Resectable MMR Proficient Gastric or Gastroesophageal Junction AdenocarcinomaP2
IMMUWINP2
PACIFIC-9P3
EMERALD-3P3
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung CancerP3
Neoadjuvant Intra-tumor Double Immunotherapy for Lung Cancer.P2
Upcoming readouts
4 ahead · durvalumab
Select a trial to load its full ClinicalTrials.gov record.
Key durvalumab trials
Top 12 of the 16 tracked phase 2–4 trials, ordered by phase and status. Trial names open the full ComplyRx trial page; NCT ids link to ClinicalTrials.gov.
Track durvalumab with ComplyRx
Get an alert when a trial changes status, moves its completion date, or a new trial registers in scope. Checked nightly against ClinicalTrials.gov.
Related drug pipelines
FAQ
- How many clinical trials are running for durvalumab?
- ClinicalTrials.gov lists more than 16 phase 2–4 durvalumab trials. This page tracks the 16 largest by enrolment: 10 phase 2, 6 phase 3, and 0 phase 4 among them, with 2 actively recruiting. Updated daily.
- Are there clinical trials for Imfinzi?
- Imfinzi is the brand name for durvalumab, so durvalumab trials on ClinicalTrials.gov cover it. ClinicalTrials.gov lists more than 16 phase 2–4 durvalumab trials. This page tracks the 16 largest by enrolment: 10 phase 2, 6 phase 3, and 0 phase 4 among them, with 2 actively recruiting. Updated daily.
- Where does this data come from?
- All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.
- Can I compare durvalumab against other drugs?
- Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.
